Emeis S.A (EMEIS) | Financial Analysis & Statements
Emeis S.A. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
13.4B
Total Liabilities
11.7B
Shareholders Equity
1.7B
Debt to Equity
6.79
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2024
Emeis S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 5.6B | 5.2B | 4.7B | 4.3B | 3.9B |
| Cost of Goods Sold | 1.1B | 1.1B | 939.3M | 731.8M | 748.8M |
| Gross Profit | 4.5B | 4.1B | 3.7B | 3.6B | 3.2B |
| Gross Margin % | 80.0% | 79.4% | 79.9% | 83.0% | 80.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | - | - |
| Other Operating Expenses | 291.3M | 303.1M | 717.0M | 250.5M | 138.3M |
| Total Operating Expenses | 291.3M | 303.1M | 717.0M | 250.5M | 138.3M |
| Operating Income | 4.2M | -120.7M | -664.3M | 364.6M | 426.4M |
| Operating Margin % | 0.1% | -2.3% | -14.2% | 8.5% | 10.9% |
| Non-Operating Items | |||||
| Interest Income | 15.2M | 10.0M | 261.0K | 433.0K | 386.0K |
| Interest Expense | 398.9M | 581.7M | 334.1M | 210.5M | 228.2M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -360.0M | 1.4B | -4.6B | 105.8M | 210.3M |
| Income Tax | 28.6M | 44.6M | -596.5M | 37.5M | 52.6M |
| Effective Tax Rate % | 0.0% | 3.2% | 0.0% | 35.5% | 25.0% |
| Net Income | -415.5M | 1.4B | -4.0B | 66.9M | 159.3M |
| Net Margin % | -7.4% | 26.2% | -86.0% | 1.6% | 4.1% |
| Key Metrics | |||||
| EBITDA | 718.7M | 3.6B | 141.1M | 1.0B | 930.4M |
| EPS (Basic) | - | €10,440.00 | €-3,979.98 | €64.50 | €158.38 |
| EPS (Diluted) | - | €10,440.00 | €-3,979.98 | €60.67 | €155.83 |
| Basic Shares Outstanding | - | 129809 | 1011825 | 1011182 | 1011137 |
| Diluted Shares Outstanding | - | 129809 | 1011825 | 1011182 | 1011137 |
Income Statement Trend
Emeis S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 518.7M | 645.0M | 856.4M | 952.4M | 888.8M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 524.0M | 518.1M | 455.4M | 431.6M | 233.2M |
| Inventory | 16.2M | 15.6M | 16.1M | 15.7M | 19.8M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 1.9B | 2.4B | 2.3B | 2.8B | 2.4B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 11.0B | 11.3B | 11.5B | 10.5B | 10.9B |
| Goodwill | 4.3B | 4.3B | 4.3B | 6.4B | 5.9B |
| Intangible Assets | 1.7B | 1.5B | 1.6B | 3.1B | 2.9B |
| Long-term Investments | 398.0K | 24.2M | 84.4M | 0 | - |
| Other Non-Current Assets | -3.0K | - | -3.0K | 1.0K | 1.0K |
| Total Non-Current Assets | 11.5B | 11.5B | 12.2B | 14.3B | 14.6B |
| Total Assets | 13.4B | 13.9B | 14.5B | 17.1B | 17.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 405.8M | 502.3M | 327.0M | 334.8M | 310.4M |
| Short-term Debt | 882.2M | 1.3B | 8.6B | 2.2B | 1.3B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 425.0M | 424.6M | 336.4M | 412.8M | 422.5M |
| Total Current Liabilities | 2.6B | 3.1B | 10.0B | 3.5B | 2.6B |
| Non-Current Liabilities | |||||
| Long-term Debt | 8.0B | 7.9B | 4.8B | 10.0B | 9.2B |
| Deferred Tax Liabilities | 730.7M | 662.5M | 814.0M | 997.0M | 1.4B |
| Other Non-Current Liabilities | -2.0K | -2.0K | - | 2.0K | 2.0K |
| Total Non-Current Liabilities | 9.1B | 8.9B | 6.0B | 11.2B | 10.8B |
| Total Liabilities | 11.7B | 12.0B | 16.0B | 14.7B | 13.5B |
| Equity | |||||
| Common Stock | 1.6M | 1.3B | 80.9M | 80.8M | 80.8M |
| Retained Earnings | -412.1M | 1.4B | -4.0B | 65.2M | 160.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.7B | 1.9B | -1.5B | 2.3B | 3.5B |
| Key Metrics | |||||
| Total Debt | 8.9B | 9.2B | 13.4B | 12.1B | 10.5B |
| Working Capital | -743.4M | -751.5M | -7.7B | -738.1M | -223.2M |
Balance Sheet Composition
Emeis S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -415.5M | 1.4B | -4.0B | 66.9M | 160.0M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -80.0M | -148.2M | -262.1M | -218.1M | -106.6M |
| Operating Cash Flow | 27.4M | -467.9M | -102.5M | 677.0M | 693.9M |
| Investing Activities | |||||
| Capital Expenditures | -143.4M | -141.0M | -136.3M | - | - |
| Acquisitions | -100.2M | -8.2M | -28.7M | -421.9M | -494.4M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -243.7M | -149.2M | -165.0M | -421.9M | -988.9M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | -58.2M | - |
| Debt Issuance | 201.3M | 500.0M | 3.4B | 2.3B | 1.7B |
| Debt Repayment | -273.2M | -972.0M | -2.5B | -991.9M | -933.5M |
| Financing Cash Flow | 318.4M | 688.1M | 898.4M | 1.3B | 811.0M |
| Free Cash Flow | 328.6M | 225.1M | 273.4M | 753.8M | 777.7M |
| Net Change in Cash | 102.1M | 71.0M | 630.9M | 1.5B | 516.0M |
Cash Flow Trend
Emeis S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
0.02
Forward P/E
153.96
Price to Book
1.58
Price to Sales
0.38
PEG Ratio
153.96
Profitability Ratios
Profit Margin
-5.06%
Operating Margin
2.38%
Return on Equity
-19.04%
Return on Assets
0.84%
Financial Health
Current Ratio
0.61
Debt to Equity
598.44
Beta
0.55
Per Share Data
EPS (TTM)
€-1.76
Book Value per Share
€8.74
Revenue per Share
€36.59
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| EMEIS | 2.3B | 0.02 | 1.58 | -19.04% | -5.06% | 598.44 |
| Orpea | 2.2B | 0.10 | - | 71.75% | 79.36% | 4.85 |
| Clariene SE | 1.4B | 9.76 | 0.38 | 0.23% | 0.03% | 200.13 |
| Ramsay Générale de | 1.1B | 34.13 | 0.98 | -2.24% | -0.86% | 343.06 |
| Lna Santé S.A | 297.5M | 12.34 | 0.93 | 6.74% | 2.65% | 2.75 |
Financial data is updated regularly. All figures are in the company's reporting currency.